Toward Illness Phase–Specific Pharmacotherapy for Schizophrenia-Reference-Cited by-同舟云学术

Toward Illness Phase–Specific Pharmacotherapy for Schizophrenia

Published:2015-12 Issue:11 Volume:78 Page:738-740
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Krystal John H.,Anticevic Alan

Funder

National Center for Advancing Translational Science

National Institute on Alcohol Abuse and Alcoholism

Center for Clinical Investigation

National Institutes of Health

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference10 articles.

1. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: Theoretical implications;Frankle;Psychopharmacology (Berl),2004

2. Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia;Kinon;Biol Psychiatry,2015

3. Rethinking schizophrenia;Insel;Nature,2010

4. Biological insights from 108 schizophrenia-associated genetic loci;Nature,2014

5. Altered markers of cortical gamma-aminobutyric acid neuronal activity in schizophrenia: Role of the NARP gene;Kimoto;JAMA Psychiatry,2015

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring causal mechanisms of psychosis risk;Neuroscience & Biobehavioral Reviews;2024-07

2. Effects of N-Methyl-d-Aspartate Receptor Antagonists on Gamma-Band Activity During Auditory Stimulation Compared With Electro/Magneto-encephalographic Data in Schizophrenia and Early-Stage Psychosis: A Systematic Review and Perspective;Schizophrenia Bulletin;2024-06-27

3. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects;Translational Psychiatry;2024-02-23

4. 40-Hz Auditory Steady-State Responses in Schizophrenia: Toward a Mechanistic Biomarker for Circuit Dysfunctions and Early Detection and Diagnosis;Biological Psychiatry;2023-10

5. Psychotic Disorders (“Schizophrenia”);Psychoneuroscience;2023